Why Brady (BRC) Is Up 7.4% After Strong Q1 Growth in Sales and Net Income

• Brady Corporation reported financial results for the first quarter ended October 31, 2025, showing sales of US$405.29 million and net income of US$53.94 million, both higher than the same quarter last year.
• The company's continued growth in both revenue and profitability highlights improvements in operational execution and underscores demand strength across its portfolio.
• With Brady producing strong year-over-year gains in sales and net income, we’ll examine how this operational momentum informs the company’s overall investment narrative.

The latest GPUs need a type of rare earth metal called Terbium and there are only 35 companies in the world exploring or producing it. Find the list for free.

Brady Investment Narrative Recap

To be a Brady shareholder, you need to believe that the company can translate steady, operational gains, such as those in its recent quarterly earnings, into long-term momentum despite headwinds in mature markets and ongoing global trade uncertainties. While strong Q1 results show clear operational progress and support near-term confidence, they do not meaningfully alter the biggest short-term catalyst, Brady’s ability to leverage R&D and acquisitions for higher-margin growth, or reduce the risk that trade policies and tariff costs could pressure future margins. Among recent corporate developments, Brady’s Q1 2026 financial results stand out as the most relevant, underscoring that profitability improvements are currently being achieved through both top-line gains and operational efficiencies. However, the continued need for cost structure actions and facility rationalization remains tightly connected to both its main catalyst, expansion into higher-growth markets, and ongoing risks tied to reliance on traditional labeling products. In contrast, investors should also pay attention to how rising global trade costs could still threaten...

Read the full narrative on Brady (it's free!)

Brady's outlook anticipates $1.7 billion in revenue and $271.5 million in earnings by 2028. This is based on a 4.1% annual revenue growth rate and a $83 million increase in earnings from the current level of $188.5 million.

Uncover how Brady's forecasts yield a $95.00 fair value, a 18% upside to its current price.

Exploring Other Perspectives

Fair value estimates for Brady from 3 Simply Wall St Community members range widely, from US$38 to US$132 per share. While some see value far above the current price, recurring cost pressures and uneven organic growth add further complexity to long-term expectations, reminding you that there are many angles to assess before making decisions.

Explore 3 other fair value estimates on Brady - why the stock might be worth less than half the current price!

Build Your Own Brady Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Brady research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Brady research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Brady's overall financial health at a glance.

Looking For Alternative Opportunities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com